FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance
FGF21 is a key metabolic regulator modulating physiological processes and its pharmacological administration improves metabolic profile in preclinical species and humans. We used native-FGF21 and a long-acting FGF21 (PF-05231023), to determine the contribution of liver and brown adipose tissue (BAT)...
Main Authors: | Bernardo, Barbara, Lu, Min, Bandyopadhyay, Gautam, Li, Pingping, Zhou, Yingjiang, Huang, Jie, Levin, Nancy, Tomas, Eva M., Calle, Roberto A., Erion, Derek M., Rolph, Timothy P., Brenner, Martin, Talukdar, Saswata |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495598/ |
Similar Items
-
Cerenkov Luminescence Imaging of Interscapular Brown Adipose Tissue
by: Zhang, Xueli, et al.
Published: (2014) -
PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates
by: Thompson, W. Clayton, et al.
Published: (2016) -
In Vivo Optical Imaging of Interscapular Brown Adipose Tissue with 18F-FDG via Cerenkov Luminescence Imaging
by: Zhang, Xueli, et al.
Published: (2013) -
Serum FGF21 levels are associated with brown adipose tissue activity in humans
by: Hanssen, Mark J.W., et al.
Published: (2015) -
Advances in the anatomic study of the interscapular region of the cat
by: Longo, Maurizio, et al.
Published: (2015)